Data / Form D filings / RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc.: Form D filings
RAPT Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 6 Form D notices with the SEC between 2016 and 2025. The latest, on January 3, 2025, reports $150 million sold of a $150 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 561 ECCLES AVENUE, South San Francisco, CA, 94080
- Phone
- (650) 489-9000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1673772
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | New notice | $149,984,200 | $149,984,200 | 20 | Dec 27, 2024 | sec.gov | |
| Jun 3, 2022 | New notice | $50,000,000 | $50,000,000 | 1 | May 27, 2022 | sec.gov | |
| Jun 20, 2019 | Amendment | $67,103,784 | $37,103,785 | $29,999,999 | 24 | Dec 18, 2018 | sec.gov |
| Jan 2, 2019 | New notice | $35,000,000 | $22,634,798 | $12,365,202 | 12 | Dec 18, 2018 | sec.gov |
| Jan 4, 2018 | New notice | $59,855,714 | $29,927,851 | $29,927,863 | 10 | Dec 15, 2017 | sec.gov |
| May 5, 2016 | New notice | $50,000,000 | $50,000,000 | 9 | Apr 21, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rodney J. Young | Executive Officer | |
| Lori V. Lyons-Williams | Director | |
| Wendye J. Robbins | Director | |
| Dirk J. Brockstedt | Executive Officer | |
| Linda J. Kozick | Director | |
| William J. Ho | Executive Officer | |
| Brian Wong | Executive Officer, Director | |
| William J. Rieflin | Director | |
| Michael Giordano | Director | |
| Mary Ann V. Gray | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RAPT Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.